YANG Han,CUI Yinfeng,FAN Zhongyi,et al.Mechanism of Fructus polygoni orientalis in treatment of liver cirrhosis based on network pharmacology[J].Journal of Yanbian University,2022,(02):132-137.
基于网络药理学探讨水红花子抗肝硬化机制
- Title:
- Mechanism of Fructus polygoni orientalis in treatment of liver cirrhosis based on network pharmacology
- 文章编号:
- 1004-4353(2022)02-0132-06
- 分类号:
- R285
- 文献标志码:
- A
- 摘要:
- 为进一步研究水红花子的药用物质基础,利用网络药理学和分子对接技术探讨了水红花子治疗肝硬化的作用机制.首先利用中药系统药理学数据库与分析平台(TCMSP)、人类基因数据库(GeneCards)、蛋白质-蛋白质相互作用网络功能富集分析平台(STRING)建立了水红花子有效成分 - 肝硬化的靶点基因网络,然后利用基因本体(gene ontology,GO)、京都基因和基因组百科全书(Kyoto encyclopedia of genes and genomes, KEGG)富集分析和分子对接手段研究了水红花子的抗肝硬化机制.研究结果显示:水红花子治疗肝硬化的成分可能是具有保肝功能的β- 谷甾醇、山奈酚、儿茶素、圣草酚、槲皮素,作用靶点可能为IL - 6、VEGFA、AKT1、TP53、CXCL8、TNF; 水红花子参与抗肝硬化的生物学过程可能有凋亡负调控、程序性细胞死亡负调控、细胞增殖调控等,相关信号通路可能包括癌症通路、细胞因子 - 细胞因子受体相互作用、Toll样受体信号通路等; 槲皮素、山奈酚与AKT1的结合能和呋塞米与AKT1的结合能相似.该研究结果可为后续研究水红花子抗肝硬化的机制提供理论依据.
- Abstract:
- To further investigate the medicinal substance basis of Fructus polygoni orientalis, the mechanism of action of Fructus polygoni orientalis in the treatment of liver cirrhosis was explored using network pharmacology and molecular docking technique. Firstly, using Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP), Human Gene Database(GeneCards), Protein - Protein Interaction Networks Function Enrichment Analysis Platform(STRING)to establish the effective component of Fructus polygoni orientalis - target genes of liver cirrhosis network, the anti - liver cirrhosis mechanism of Fructus polygoni orientalis was then investigated by GO(gene ontology)and KEGG(Kyoto encyclopedia of genes and genomes)enrichment analysis of the intersecting genes of Fructus polygoni orientalis and liver cirrhosis, combined with molecular docking method.The results of the study show that the effective components for the treatment of liver cirrhosis of the Fructus polygoni orientalis may be β - sitosterol, kaempferol, catechin, eriodictyol, quercetin, which have the function of protecting the liver, the targets of action may be IL - 6, VEGFA, AKT1, TP53, CXCL8, TNF; Fructus polygoni orientalis is involved in the biological processes of treating liver cirrhosis, which may include negative regulation of apoptosis, negative regulation of programmed cell death, regulation of cell proliferation and so on. The signal pathways related to the treatment of liver cirrhosis by Fructus polygoni orientalis may include pathways in cancer, cytokine - cytokine receptor interaction, toll - like receptor signaling pathway and so on. In addition, the binding energies of quercetin and kaempferol with AKT1 are similar to those of furosemide. The results of this study may provide a theoretical basis for subsequent in - depth studies on the mechanism of Fructus polygoni orientalis against liver cirrhosis.
参考文献/References:
[1] 苏林红,柳侠平,林军.茵陈五苓散对肝硬化腹水大鼠模型的影响[J].中国现代应用药学,2020,37(2):161 - 164.
[2] 于聪聪.水红花子汤治疗血瘀型肝硬化腹水的疗效研究[D].济南:山东中医药大学,2013.
[3] 杨白苗.分析血瘀型肝硬化腹水采用水红花子汤治疗的临床效果[J].航空航天医学杂志,2014,25(11):1587 - 1588.
[4] 张宇雪,李勇.水红花子汤治疗代偿期肝硬化验案[J].内蒙古中医药,2018,37(3):26 - 27.
[5] 孙洁,姚晓泉,刘永铭,等.水红花子名称及其与蓼实关系的本草考证[J].中药材,2019,42(4):931- 934.
[6] 杜宇琼,车念聪,高彦彬,等.水红花子现代药理作用研究进展[J].北京中医药,2015,34(12):993 - 995.
[7] XU X, ZHANG W, HUANG C, et al.A novel chemometric method for the prediction of human oral bioavailability[J].International Journal of Molecular, 2012,13(6):6964 - 6982.
[8] TAO W, XU X, WANG X, et al.Network pharmacology - based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease[J].Journal of Ethnopharmacology, 2013,145(1):1 - 10.
[9] HUANG J, CHEUNG F, TAN H Y, et al.Identification of the active compounds and significant pathways of yinchenhao decoction based on network pharmacology[J].Molecular Medicine Reports, 2017,16(4):4583 - 4592.
[10] XIAO Q, YU H B, ZHU X.The associations of hub gene polymorphisms in PI3K/AKT/mTOR pathway and Schistosomiasis Japonica infection and hepatic fibrosis[J].Infection Genetics and Evolution, 2020,85:104423.
[11] 周晓玲,韦宛华,陈峭,等.麻黄升麻汤对肝硬化腹水并感染大鼠血清炎性因子的干预作用[J].中华中医药杂志,2019,34(4):1409 - 1414.
[12] CHEN X, ZHANG L, CHANG Y, et al.Association of TNF - α genetic polymorphisms with hepatocellular carcinoma susceptibility: a case - control study in a Han Chinese population[J].The International Journal of Biological Markers, 2011,26(3):181 - 187.
[13] WU K, KRYCZEK I, CHEN L P, et al.Kupffer cell suppression of CD8(+)T cells in human hepatocellular carcinoma is mediated by B7 - H1/programmed death - 1 interactions[J].Cancer Research, 2009,69(20):8067 - 8075.
[14] 王璐,张礼欣,贾奥蒙,等.基于指纹图谱和网络药理学对经典名方竹茹汤中葛根的质量标志物(Q - Marker)预测分析[J].中草药,2021,52(20):6197 - 6207.
[15] 宗阳,丁美林,贾可可,等.基于网络药理学和分子对接法探寻达原饮治疗新型冠状病毒肺炎(COVID - 19)活性化合物的研究[J].中草药,2020,51(4):836 - 844.
[16] 裴超,邵霖霖,刘晶,等.基于网络药理学与分子对接技术探讨红花治疗视网膜静脉阻塞的作用机制研究[J].天然产物研究与开发,2020,32(11):1844 - 1851.
[17] 刘翠翠,杨晨,杨涛,等.基于网络药理学和分子对接探讨银杏叶治疗高血压病潜在作用机制[J].天然产物研究与开发,2021,33(3):468 - 478.
[18] 陈廷玉,陈德顺,何帅兵,等.ROS/JNK通路在槲皮素抑制异烟肼诱导肝细胞凋亡中的作用[J].湖州师范学院学报,2021,43(8):59 - 64.
[19] 费曜,段恒,牛亚珍,等.藏药“松蒂”(篦齿虎耳草)中黄酮类成分对L02肝细胞氧化损伤的影响[J].中药新药与临床药理,2021,32(9):1260 - 1267.
[20] HUNG W L, YANG G, WANG Y C, et al.Protective effects of theasinensin A against carbon tetrachloride - induced liver injury in mice[J].Food & Function, 2017,8(9):3276 - 3287.
[21] BINMOWYNA M N, ALFARIS N A.Kaempferol suppresses acetaminophen - induced liver damage by upregulation/activation of SIRT1[J].Pharmaceutical Biology, 2021,59(1):146 - 156.
[22] WANG H, CHEN L, ZHANG X, et al.Kaempferol protects mice from d - GalN/LPS - induced acute liver failure by regulating the ER stress - Grp78 - CHOP signaling pathway[J].Biomedicine & Pharmacotherapy, 2019,111:468 - 475.
[23] XU T, HUANG S, HUANG Q, et al.Kaempferol attenuates liver fibrosis by inhibiting activin receptor - like kinase 5[J].Journal of Cellular and Molecular Medicine, 2019,23(9):6403 - 6410.
[24] 张亦凡,刘功关,刘茜,等.圣草酚抑制自由基诱导的生物大分子损伤及对肝癌细胞HepG2毒性的作用[J].食品科学,2013,34(17):126 - 130.
[25] 王招玉.葡萄糖醛酸化代谢在圣草酚减弱对乙酰氨基酚肝毒性中的作用研究[D].广州:南方医科大学,2018.
[26] 李庆勇,姜春菲,张黎,等.β- 谷甾醇、豆甾醇诱导人肝癌细胞SMMC - 7721凋亡[J].时珍国医国药,2012,23(5):1173 - 1175.
[27] 张忠泉,邢煜君,胡国强,等.β- 谷甾醇诱导人肝癌HepG2细胞凋亡机制研究[J].中国中药杂志,2011,36(15):2145 - 2148.
备注/Memo
收稿日期: 2021-09-12
基金项目: 延边大学校企合作项目(延大科合字(2019)第40号)
第一作者: 杨涵(1997—),女(满族),硕士研究生,研究方向为天然药物活性成分.
通信作者: 金莉莉(1978—),女(朝鲜族),博士,副教授,研究方向为天然药物活性成分.